Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar 27;94(6):828-34.
doi: 10.1038/sj.bjc.6603029.

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer

V Jenkins  1 , V Shilling, G Deutsch, D Bloomfield, R Morris, S Allan, H Bishop, N Hodson, S Mitra, G Sadler, E Shah, R Stein, S Whitehead, J Winstanley
Affiliations

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer

V Jenkins et al. Br J Cancer. .

Abstract

The neuropsychological performance of 85 women with early stage breast cancer scheduled for chemotherapy, 43 women scheduled for endocrine therapy and/or radiotherapy and 49 healthy control subjects was assessed at baseline (T1), postchemotherapy (or 6 months) (T2) and at 18 months (T3). Repeated measures analysis found no significant interactions or main effect of group after controlling for age and intelligence. Using a calculation to examine performance at an individual level, reliable decline on multiple tasks was seen in 20% of chemotherapy patients, 26% of nonchemotherapy patients and 18% of controls at T2 (18%, 14 and 11%, respectively, at T3). Patients who had experienced a treatment-induced menopause were more likely to show reliable decline on multiple measures at T2 (OR=2.6, 95% confidence interval (CI) 0.823-8.266 P=0.086). Psychological distress, quality of life measures and self-reported cognitive failures did not impact on objective tests of cognitive function, but were significantly associated with each other. The results show that a few women experienced objective measurable change in their concentration and memory following standard adjuvant therapy, but the majority were either unaffected or even improve over time.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cognitive test battery.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bender C, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM (2005) Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-oncology, Aug 12 [Epub ahead of print] - PubMed
    1. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G (1997) Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 15: 974–986 - PubMed
    1. Broadbent D, Cooper PF, FitzGerald P, Parkes KR (1982) The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 21(Part 1): 1–16 - PubMed
    1. Burgess C, Ramirez A, Cornelius V, Love S, Graham J, Richards M (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330: 702–705 - PMC - PubMed
    1. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA (2005) The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 59: 60–70 - PubMed

Publication types

MeSH terms

Substances